Research ArticleOriginal Article

Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases

Yue-Ya Li, Chan Zhou, Deng-Xia Yang, Jing Wang, Zhu-Jun Liu, Xin-Yue Wang and Kai Li
Cancer Biology & Medicine June 2015, 12 (2) 117-125; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0012

Article Information

vol. 12 no. 2 117-125
DOI 
https://doi.org/10.7497/j.issn.2095-3941.2015.0012
Published By 
Cancer Biology & Medicine
History 
  • Received February 5, 2015
  • Accepted May 18, 2015
  • Published online June 1, 2015.
Copyright & Usage 
Copyright: © 2015 Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Yue-Ya Li1,
  2. Chan Zhou1,
  3. Deng-Xia Yang1,
  4. Jing Wang1,
  5. Zhu-Jun Liu1,
  6. Xin-Yue Wang1 and
  7. Kai Li1⇑
  1. 1Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Lung Cancer Diagnosis and Treatment Center, Tianjin 300060, China
  1. Correspondence to: Kai Li E-mail: likai5{at}medmail.com.cn
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords